Tepezza For Thyroid Eye Disease Gets FDA Approval

The U.S. Food and Drug Administration (FDA) has granted Horizon Therapeutics Ireland DAC approval for teprotumumab-trbw as treatment in adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, ca ...

Article - News Staff - Jan 21 2020 - 5:36pm